Search Videos and More
Video
Young-Onset Colorectal Cancer Center Gut Instincts Series: Best Practices for Symptom Management
Dana-Farber’s Young-Onset Colorectal Cancer Center's Gut Instincts series continued on Tuesday, January 25 with an educational workshop on Best Practices for Symptom Management.
Symposium
Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management
This course addresses the rapidly changing landscape in the management and treatment of non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia.
News
Race, Ethnicity, and Poverty Linked to Worse Outcomes in Children Treated for High-Risk Neuroblastoma
Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Video
cHL and CLL SLL Panel Discussion and Conclusion
In this video, the panel takes audience questions and discusses cases of Classical Hodgkin Lymphoma, Chronic Lymphocutic Leukemia, and Small Lymphocytic Lymphoma.
Video
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Inhye Ahn, MD, discusses the background and management of chronic lymphocytic leukemia and small lymphocytic lymphoma.
Video
Hodgkin Lymphoma
Ann LaCasce, MD, MMSc, discusses Hodgkin lymphoma and how to approach the different types of Hodgkin patients.
Video
CAR-T Cell Therapy for Lymphoma: Updates and Progress
Caron Jacobson, MD, MMSc, gives updates and shares progress with CAR-T cell therapy for lymphoma.
News
Combination Therapy Produces Encouraging Results in Patients with Gynecologic Cancers with Distinct Genetic Mutations
A two-drug therapy that sets certain cancer cells up for failure and then finishes them off showed encouraging activity in a clinical trial of patients with gynecologic cancers that harbor mutations in a key gene, Dana-Farber investigators reported at the Society for Gynecologic Oncology (SGO) Annual Meeting in March.
Video
Transatlantic Exchanges in Immuno-Oncology
Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology!
News
Newly Identified Regulator in Prostate Cancer Cells Could Serve as Drug Target for Advanced Tumors
Aiming to discover new targets for blocking androgen receptor activity, a Dana-Farber-led team has identified a critical regulator of AR signaling that prostate cancer cells depend on, according to their publication in Cell Reports.
Document
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings on August 4, September 3, October 8, 2021, and June 24, 2022 to discuss recommendations for the use of pembrolizumab in patients with early-stage TNBC.
Symposium
Breast Cancer Treatment Guidelines
Following the FDA approval of certain treatments for breast cancer, the faculty in the Breast Oncology Program at Dana-Farber Brigham Cancer Center met to formalize guidelines for how to best utilize the new medications.